Inquiry
메인콘텐츠 바로가기 메뉴영역 바로가기
하이로닉 로고

하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.

인터내셔널 웹사이트 →

It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.

International Website →
닫기
하이로닉 로고

하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.

US 웹사이트 →

It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.

US Website →
닫기
하이로닉 로고

하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.

EU 웹사이트 →

It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.

EU Website →
닫기
NEWS
  • 제목HIRONIC: SILKRO™ DEVICE EXPANDS WITH FDA-APPROVED PLASMA HANDPIECE
  • 조회수3,926
  • 작성일24-07-03 16:32
Dear Partners,

We are sharing a significant update from HIRONIC that promises to enhance our global competitiveness and innovation in medical aesthetic technology. Our multifunctional RF aesthetic device, Silkro™, has received FDA 510(k) clearance for an exciting

New addition: the Plasma (PS) handpiece.

Silkro™, which utilizes micro-needle technology to deliver high-frequency (RF) currents for tissue coagulation and pain relief, previously featured four types of handpieces: RM (RF Micro Needle), RN (RF Needle), RC (RF Circle), and RV (RF Vaginal). 

When combined with RF treatment, plasma enhances therapeutic outcomes by intensifying energy delivery and improving precision, which facilitates more effective tissue coagulation and healing. It also brings sterilizing and disinfecting benefits by generating reactive species that effectively destroy bacteria and viruses, reducing the risk of infection and promoting a safer treatment environment. This synergy results in more efficient treatments with potentially shorter recovery times and improved results. 

This latest FDA approval underlines HIRONIC’s relentless pursuit of excellence and innovation. It reaffirms our technological prowess and the safety of our products on an international stage, strengthening our position in the global market. 

We look forward to the opportunities this expansion will bring and are excited to see the positive impact it will have on your markets. Thank you for your continued support as we push the boundaries of medical aesthetic technology together.

e18272ad6b714d755ff242aeafa3ac6e_1719991

  • 관련 URL
  • 첨부파일